Carlo Towl Profile
Carlo Towl

@Towlie1981

Followers
370
Following
261
Media
153
Statuses
5,372

Public servant and private investor. Building capital to enjoy life and retire young!

Exeter, England
Joined June 2012
Don't wanna be here? Send us removal request.
Explore trending content on Musk Viewer
@Towlie1981
Carlo Towl
2 months
@ArgyleBecky Are you having a laugh? Police are human beings that need food and drink the same as everyone else. Their place of work is the street most of the time and it's not unprofessional to eat and drink as long as they are still able to complete their duties.
8
5
737
@Towlie1981
Carlo Towl
1 month
@AgrippaSPQR @Councillorsuzie I can't believe this lie has been amplified by so many twitter accounts. Watch the video. He literally shakes her hand a second after this because he initially didn't realise she was offering it, but when he does, he shakes it.
11
11
262
@Towlie1981
Carlo Towl
2 months
Let's remember that this patient had already had: radiotherapy, surgery and immunotherapy prior to having 6K. All of which didn't work and it had progressed to stage 4 when he enrolled. Absolutely astounding. #AVCT
@sharesearch_
sharesearch
2 months
#AVCT “patient with Near complete resolution” of tumours.
Tweet media one
2
10
66
7
18
120
@Towlie1981
Carlo Towl
5 months
@LeeCraddock12 Interesting that you don't understand what would happen if we allow Russia to go unchecked. History tends to repeat itself, so we should use history to help us make the right decisions.
38
1
99
@Towlie1981
Carlo Towl
2 years
@johnredwood UK companies are ready and waiting for @UKHSA approval. @avacta , @Omega_ODX and @Abingdon_Health have world beating LFTs that are more accurate than Chinese alternatives and manufacturing capacity in the millions, but @DHSCgovuk overlooks them in favour of imports.
1
13
83
@Towlie1981
Carlo Towl
3 years
Just had a chat with the customer services manager at Bioserve about why my order has been pushed back to 27th Aug. 'Exceptional demand' was said a few times and they've had to place a larger order to try and fulfill that demand #AVCT
9
5
76
@Towlie1981
Carlo Towl
9 months
@BenPBradshaw Of all the Tories I want to see unseated, his is the one I want to see the most.
4
1
75
@Towlie1981
Carlo Towl
9 months
#AVCT currently in the sweet spot. Technicals look good so the traders are buying, potential is off the scale so the speculators are buying, a milestone RNS is due, enough cash til next summer, rumours are swirling of blockbuster efficacy in a P1a trial. LT holders just chilling.
2
7
74
@Towlie1981
Carlo Towl
2 years
Angela Rayner calling Govt out on buying LFTs from China and not from UK companies #AVCT #ODX #ABDX
1
9
71
@Towlie1981
Carlo Towl
6 months
Does anyone really think they announce the presentation of data 9 days in advance for it to be a damp squib? This is being stage managed for maximum effect #AVCT
@avacta
Avacta
6 months
Shareholder update to review AVA6000 Phase 1a data. #AVCT
4
37
183
1
4
70
@Towlie1981
Carlo Towl
1 year
@Rob_Kimbell It's easy to be the fastest growing when you start from such a low base.
Tweet media one
10
2
65
@Towlie1981
Carlo Towl
11 months
@Gerashchenko_en What an utterly pointless country Russia is.
2
2
63
@Towlie1981
Carlo Towl
2 months
Anyone with any semblance of understanding of what's been happening in recent years with ADCs will understand the below comment is a signpost that Avacta has a multi billion dollar platform on its hands #AVCT
Tweet media one
2
5
64
@Towlie1981
Carlo Towl
2 months
A reminder that in 2015 Ketruda posted a 75% disease control rate on 1 specially selected indication in order to increase chances of positive results. #AVCT just posted 67% which included numerous tumours known to not be responsive to dox.
Tweet media one
3
9
61
@Towlie1981
Carlo Towl
4 months
If after all this time and everything they've achieved all #AVCT can rustle up is a discounted placing then that will be biggest disappointment of all time with all the 'optionality' and multiple statements saying they're prioritising non dilutive funding, etc. We will see.
10
3
58
@Towlie1981
Carlo Towl
10 months
@tomhfh Just a quick reminder that public sector pay rises averaged 6.2% in the most recent figures. The private sector continued to outpace the public sector at 8.2%. The private sector makes up 82.4% of the workforce. You client journalists do make me laugh with your propaganda.
0
0
57
@Towlie1981
Carlo Towl
2 months
"we know the value of the platform. Doing small, quick deals is not attractive or sensible." "data and cash runway important for a strong negotiating position. We now have both" "Can't think of another way to describe it" (when asked about it being Holy Grail). #AVCT
1
1
55
@Towlie1981
Carlo Towl
6 months
"Recently announced clinical data that have already begun to generate interest from potential commercial partners." Did anyone really believe that pre|CISION hadn't already generated commercial interest? #AVCT
@avacta
Avacta
6 months
Appointment of Simon Bennett as Chief Business Officer of the Therapeutics Division. #AVCT
4
41
187
3
3
55
@Towlie1981
Carlo Towl
7 months
Bloody hell #AVCT is hard out of the blocks this morning. It's almost like they're on the verge of announcing something big! Anyone would think the company has signposted it for months 😃
1
2
54
@Towlie1981
Carlo Towl
1 year
Game changing. Life changing. Revolutionary. Well done to all genuine holders. To those who held through all the noise. We deserve this. As do the millions of cancer sufferers around the world. It's just a matter of time now before a buyout #AVCT
@avacta
Avacta
1 year
Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study. #AVCT
49
146
514
1
5
52
@Towlie1981
Carlo Towl
8 months
At this point anyone selling or talking it down has completely lost it! Most exciting company on the planet currently for both humankind and for investors. Things will move quicker than anyone thinks #AVCT
@Andrewp37075755
Andrew presley
8 months
@tom_the_bomb__ Note who Janet is and where she works
Tweet media one
3
2
64
1
4
51
@Towlie1981
Carlo Towl
9 months
@RAH00084 The results are of P1a/b are going blow apart how cancer therapies are looked at across chemo, ADCs and next gen drugs. The ability to have something so targeted that can improve almost every drug that treats solid tumours is going to redefine the oncology world imo #AVCT
2
3
52
@Towlie1981
Carlo Towl
2 years
So they had £17 million in the bank at 30th June and are losing £9 million pa. So they're funded til mid 2023, exactly as they've been saying all along. All this distressed placing bull can hopefully now stop. Plenty of time for a non-dilutive licence #AVCT
1
2
51
@Towlie1981
Carlo Towl
7 months
@Bren4Bassetlaw @GaryLineker The sooner like likes of you, Lee Anderson and Gullis are voted out the better. Embarrassing.
1
2
48
@Towlie1981
Carlo Towl
9 months
The most important part of the #AVCT RNS? The fact they've binned P1b and are moving to a potentially pivotal P2. What have they seen in the P1a data that has caused this? If you can't work that one out there's no helping you 😂
2
2
49
@Towlie1981
Carlo Towl
17 days
Meanwhile the trial continues to go swimmingly with new partnerships to enrich the study. Ignore the noise, a unicorn is being created. #AVCT
@avacta
Avacta
17 days
Successful Completion of First Cohort and Dosing of Three Patients of the Second Cohort in Arm 2 of Avacta’s AVA6000 Phase 1 trial. #AVCT @sofiebio
10
37
197
4
0
46
@Towlie1981
Carlo Towl
3 years
@paulwaugh It's an absolute disgrace. Superior tests developed and manufactured by @avacta , @mologic , @OmegaDiagnostic and @Abingdon_Health would not only be a similar price to Innova, but also more accurate, a boon to UK industry and govt tax receipts #AVCT #ODX #ABDX
0
6
45
@Towlie1981
Carlo Towl
2 years
Forget pre-CISION, I've moved on to TMAC already 😂. Full update in 2022. #AVCT (I'm aware it can't work without a successful pre-CISION)
Tweet media one
4
3
44
@Towlie1981
Carlo Towl
8 months
CEO spent a lot of time emphasising that 6k isn't the prize here, cos pre|CISION is a PLATFORM & that PLATFORM is now validated. Funded til late 24 but regarding getting non dilutive funding "YOU DONT NEED TO WORRY ABOUT THAT" Hints at licenses being close and DX to be sold #AVCT
1
0
44
@Towlie1981
Carlo Towl
11 months
@afneil So what you're saying is the government will be representative of what the people voted for..... Sounds like a good thing to me!
2
0
42
@Towlie1981
Carlo Towl
1 year
@MatthewStadlen @sophielouisecc Yup. And 75% of them support the monarchy.
26
0
41
@Towlie1981
Carlo Towl
11 months
@mrjamesob It's all very Trumpian. I don't like it.
0
0
41
@Towlie1981
Carlo Towl
8 months
Twitchy bum time for the boys in red #AVCT
Tweet media one
4
3
41
@Towlie1981
Carlo Towl
2 years
Wink wink nod nod. AVA6000 is working as planned. I expect a muted response as most investors have no idea what Avacta is sitting on. #AVCT
@avacta
Avacta
2 years
Avacta Selects Second pre|CISION Pro-drug Candidate for Development. #AVCT
7
31
182
2
1
40
@Towlie1981
Carlo Towl
6 months
Lots of frustrated investors by the looks of the SP due to no commercials. Fact still remains this is revolutionary tech that will be worth billions. It's just a matter of when. Are you a trader or an investor? #AVCT
3
2
40
@Towlie1981
Carlo Towl
9 months
- significant efficacy in end of life patients. - P1b canned. Pivotal P2 instead. SOC for Soft Tissue Sarcoma within 2 years = 100s of millions of revenue within 2-3 years. - Twice weekly dosing. - "Paradigm shift in the use of chemo". #AVCT
0
3
39
@Towlie1981
Carlo Towl
5 months
Yes. Yes it is. Can you please tell the market? 😂 #gamechanging #AVCT
@coughlin582
Christina Coughlin
5 months
I am thrilled to join @avacta full time at such a pivotal time in the Company’s growth. Our #AVCT pipeline is truly game changing for patients with cancer and I am excited to get to work with this amazing team. #BringingHope #LetsDoThis
26
40
392
0
0
40
@Towlie1981
Carlo Towl
1 year
So Clovis sell their FAP targeting drug to Novartis while in bankruptcy (distressed sell = low price) for over $500m. If #AVCT show AVA6000 works like the preclinical results then 6K alone is worth billions to big pharma. PreCISION is a PLATFORM. Market cap currently £280m.
1
1
40
@Towlie1981
Carlo Towl
3 months
"The scale of the opportunity being presented is positively breathtaking". No wonder every II, specialist healthcare investor and retail investor were so keen to get in at the stupidly cheap price of 50p. #AVCT
Tweet media one
6
1
39
@Towlie1981
Carlo Towl
1 year
@Rob_Kimbell Brexiteers are now complaining about the fact they won and Brexit has been implemented 😂
10
0
37
@Towlie1981
Carlo Towl
11 months
@OTVDesk @tomhfh No. "Detectives from the Met's Specialist Crime Command have now concluded their assessment and have determined there is no information to indicate that a criminal offence has been committed."
5
0
37
@Towlie1981
Carlo Towl
2 months
Deals incoming. Company quite rightly putting themselves into the best negotiating position before signing them to get better deals. Precedent suggests up front payments for licences at least in the 10s of millions, possibly 100s, with total value up to the billions #AVCT
@tom_the_bomb__
⛏🅾️Ⓜ️
2 months
Many traders/investors have said we need a deal to move on from this level. This clip now provides clear guidance that (1) small deals are easy (but not recommended) & (2) #AVCT want the right, higher value deals for shareholders, which understandably require patience. 1/2
6
4
66
1
0
39
@Towlie1981
Carlo Towl
2 years
@avacta @theNCI @scale_space @HelloUpstream @WCIDLondon @imperialcollege @LBHF So the Principle Investigator for the AVA6000 trial is talking about localising cytotoxic anti cancer therapy 6 weeks before potentially company defining news on the 6k trial after over a year of data. Are you trying to tell us something? #AVCT
4
2
39
@Towlie1981
Carlo Towl
9 months
It seems the market is finally catching on. Next week should be interesting. I'm predicting a blockbuster RNS #AVCT
2
0
38
@Towlie1981
Carlo Towl
2 years
I'm enjoying the renewed sentiment in #AVCT . Good data mid year will see this blow past £2 and head towards £5. Diagnostics is still rumbling along and key partnerships progressing. Lots to get excited about. I still think a TO is the most likely outcome if data from P1a is good.
3
4
37
@Towlie1981
Carlo Towl
9 months
"Several patients remain on trial in different dose cohorts and continue to receive AVA6000 as their disease has not progressed" If you read this in the June 21st RNS but didn't buy in since because it's a 'risky P1 trial' then you deserve to miss the fireworks. #AVCT
0
1
38
@Towlie1981
Carlo Towl
1 year
I've been wondering what catalyst would push the SP through 130p resistance. Turns out it's a missed deadline! Well I never - I think this company might have something you know 🤣 #AVCT
1
1
37
@Towlie1981
Carlo Towl
1 year
It's almost as if the further into the trial they go the more they realise what they are sitting on and don't want to give it away. Potentially 2 x bn $ plus drugs that could revolutionise cancer treatment. Enough cash to prove pre|CISION. They ain't giving it away cheap #AVCT
1
1
36
@Towlie1981
Carlo Towl
6 months
@Blueberrymgmnt There just HAS to be a substantial deal being worked on, whether it be a licence, a JV, an offer for the whole company or any other type of deal. It's all just too quiet for that not to be the case imo #AVCT
4
0
36
@Towlie1981
Carlo Towl
1 year
Avacta investors old and new. Read this, then read it again. And again. Fully digest it. Because what Avacta has done here is truly revolutionary for cancer suffers. The SP may take time to catch up with the immense potential reach of this tech, but it will eventually #AVCT
@MylesMcNulty
Myles McNulty
1 year
#AVCT 's update today is without doubt the most significant RNS I have ever read, from any company. Update note in the coming days, but here are some initial thoughts. Firstly - what many want to hear - the SP at 155p (mkt cap £412m). In my view, this will not last long. 1/20
23
49
243
0
6
35
@Towlie1981
Carlo Towl
2 months
I think for the first time in history we're going to see AS over deliver in the coming weeks. Market has lost all hope. Sentiment on the floor. No pre AACR rise. Rubbish chart. No nothing. But that doesn't mean anything has changed for the outlook of the company. Buy. #AVCT
4
0
34
@Towlie1981
Carlo Towl
1 month
Just bagged #AGL again. The time to buy was when price action and sentiment was terrible. The IP was all that mattered in the LT. Same true of #AVCT now.
5
0
34
@Towlie1981
Carlo Towl
1 year
@MylesMcNulty @avacta Unbelievable!!! I fully expect a 1% rise tomorrow on the back of it 😂
3
0
34
@Towlie1981
Carlo Towl
5 months
@LeeCraddock12 Yeah there probably should be an audit. However not doing it almost certainly leads to further land grabs in the East after he takes Ukraine and a larger war directly involving the West. In which case we'll all be a lot poorer as the economy moves into a war economy.
4
0
32
@Towlie1981
Carlo Towl
3 years
Between 5-30mil manufac pm. Looking for more. Dialogue with UK Gov (sovereign test), distributors across Europe and licensing ops. USA to be tapped up in due course. #AVCT
Tweet media one
Tweet media two
3
4
33
@Towlie1981
Carlo Towl
5 months
The market doesn't believe #AVCT , #AGL or #BSFA will sign any commercial deals in the near term. However if you've been paying attention you will have seen the opportunity in all 3 at the lows and deals will flow in 2024. What an opportunity this dysfunctional market gives us!
1
1
33
@Towlie1981
Carlo Towl
1 year
I do believe the tide has turned in #AVCT . The realisation that they are changing the game in cancer treatment is dawning. There's still a long way to go but this is the best investment on AIM at these prices in the LT.
0
3
32
@Towlie1981
Carlo Towl
2 years
@MarinaPurkiss @avacta , @Abingdon_Health , @mologic and @Omega_ODX all have superior quality LFTs than current free ones and manufacturing capacity for approx 8 millions tests pw, yet Gov are more interested in ignoring them or cancelling contracts with them than supporting British industry.
0
11
32
@Towlie1981
Carlo Towl
1 year
@Cumulus51896691 It's worth remembering that if pre|CISION works as preclinical it is completely peerless in what it does. There is nothing else that targets FAP in the same way so it could take that entire market eventually, solving an age old issue that pharma has been trying to solve #AVCT
0
1
31
@Towlie1981
Carlo Towl
3 months
With the raise now done we can concentrate on what has always been a world beating platform and hope that the CEOs words actually ring true this time around commercials #AVCT
Tweet media one
@avacta
Avacta
3 months
Update on AVA6000 Phase 1a Clinical Trial Progress. #AVCT
5
24
135
2
1
31
@Towlie1981
Carlo Towl
1 year
Hello efficacy #AVCT
Tweet media one
1
0
31
@Towlie1981
Carlo Towl
2 years
#AVCT #ODX #NCYT #ABDX Boris Johnson: Stopping use of Chinese inaccurate lateral flow tests and support UK home made diagnostics - Sign the Petition! via @UKChange
1
6
31
@Towlie1981
Carlo Towl
10 months
When the data drops some are going to have their pants pulled down big time. You will hear the words 'game changing' a lot. I believe that game changing efficacy is already being observed. Like I've said for 3 years - hold and add on dips. Proper conviction stock #AVCT
@tom_the_bomb__
⛏🅾️Ⓜ️
10 months
One day many will look back and wished they believed the below could be possible. @jivetur88775834 👏 #AVCT
Tweet media one
Tweet media two
2
3
55
1
0
31
@Towlie1981
Carlo Towl
2 years
@TanDhesi 👏Finally MPs are giving this the attention it deserves! Keep digging and you will find it's a lot worse than you thought.
0
0
31
@Towlie1981
Carlo Towl
6 months
@asininitybeyond Unfortunately many just don't believe what this company has achieved and the magnitude of it. It's ok though cos it doesn't matter what PIs or IIs think because big pharma will value it even if the market can't/won't #AVCT
0
2
31
@Towlie1981
Carlo Towl
2 years
“Anything that we can do to displace systemic chemotherapy with something more efficacious gets me enthusiastic.” Dave Fredrickson, executive vice president of AstraZeneca’s oncology business unit. #AVCT
0
3
30
@Towlie1981
Carlo Towl
3 years
What does #ABDX rise today tell me about #AVCT ? That any sniff of reasonable revenue or HUA will see it at least back at recent highs in a matter of days. Massively oversold with negative sentiment just like Abingdon was. Sticky hands will prevail.
3
2
30
@Towlie1981
Carlo Towl
2 years
Saturn Pass now compatible with NHS LFTs 👀 #AVCT
Tweet media one
0
3
30
@Towlie1981
Carlo Towl
1 year
CEO 20/21; "we will look to license AVA6000 once we have data" 22; "it would be a mistake to license our lead asset but will look to licence those behind it" 23; "it would be a mistake to license our 2 most advanced assets but cld license pre|CISION co's developing ADCs" #AVCT
2
0
30
@Towlie1981
Carlo Towl
2 years
The first stage of cancer treatment being revolutionised. Amazing news for cancer suffers world wide and terrible news for shorters #AVCT
@avacta
Avacta
2 years
Avacta Announces Dose Escalation in the Phase I Clinical Study of AVA6000 Pro-doxorubicin. #AVCT
23
50
276
0
2
30
@Towlie1981
Carlo Towl
2 years
What we've all been waiting for. Things should pick up nicely from here 😀. Also goes to prove that @Bishop5022 is a lying, de-ramping fool (as if we didn't already know.) #AVCT
@avacta
Avacta
2 years
AffiDX® SARS-CoV-2 Antigen Lateral Flow Test Receives CE Mark for Consumer Self-Testing. #AVCT
Tweet media one
30
91
368
2
2
30
@Towlie1981
Carlo Towl
9 months
Can you imagine the margin calls on those shorts today 😂 #AVCT
5
0
29
@Towlie1981
Carlo Towl
5 months
@MylesMcNulty @Antonyblood1 @EliLillyandCo @avacta Also.... “In our domains of expertise, we better be able to call balls and strikes better than our competitors and maybe better than even venture capital. And if we can do that, we can pick winners,” Ricks said. Basically markets can't value a company to save their lives #AVCT
1
0
29
@Towlie1981
Carlo Towl
8 months
Another massive signpost as to where #AVCT is heading. Point sub-licensed pre|CISION from Avacta if you didn't know and re-named it 'CanSeek'. Their tech was made A LOT better by it.
@Cumulus51896691
Cumulus
8 months
#AVCT The plot thickens, another one goes for FAP....
4
11
119
0
3
28
@Towlie1981
Carlo Towl
1 year
My favourite thing that came out of AACR. Confirmation from the CSO that there is lots of interest in AVA3996 and the pre|CISION platform in general. MOA confirmed. Talks will be commencing/ongoing on licenses imo. #AVCT
Tweet media one
0
2
28
@Towlie1981
Carlo Towl
2 years
#AVCT has awoken finally. Only another 80% rise til I breakeven! Always been a massive conviction hold for me.
2
0
27
@Towlie1981
Carlo Towl
2 years
@DeNummer6 @emilydugan @UKHSA @emilydugan , there is more to your story than you uncovered. Frozen samples, pigs mucus, Innova continuing to be used despite US Gov advising they are 'thrown in the trash'. #AVCT
Tweet media one
0
8
28
@Towlie1981
Carlo Towl
6 months
@RAH00084 Here's their note on 30th June 2022. Successful proof of concept would lead to a 'material uplift in our AVA6000 valuation'. Yet AVA6K does exactly that and the valuation of it goes up by 4p (20p to 24p). pre|CISION goes from 102p then to 104p now. Ridiculous. #AVCT
Tweet media one
3
2
28
@Towlie1981
Carlo Towl
2 years
@YorkshirPuddin It's simple really. Would the world prefer chemo with side effects or chemo without. If the answer is without, it will be the only form of chemo going forward, regardless of the efficacy on the tumour. #AVCT
0
1
28
@Towlie1981
Carlo Towl
8 months
PLATFORM technology. pre|CISION can target almost any drug to a tumour to make it more efficacious and have less side effects. How much is that worth? Market = 😴😴😴😴😴 #AVCT
@avacta
Avacta
8 months
We will be in Boston next week to present positive new data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics. See you all there! #AVCT #cancerresearch #innovation #oncology
Tweet media one
9
56
264
0
1
28
@Towlie1981
Carlo Towl
1 year
"Man with reputation for growing and selling companies joins board" #AVCT
@avacta
Avacta
1 year
Director Appointment. #AVCT
0
8
86
0
2
27
@Towlie1981
Carlo Towl
2 years
Pre-clinical data. However they could have applied for this prior to the trial starting as they've had the data for a long time, but they didn't. I wonder what happened in the first 9 months of the clinical trials that gave them the confidence to go for Orphan designation?! #AVCT
@avacta
Avacta
2 years
AVA6000 receives Orphan Drug Designation from the US Food and Drug Administration. #AVCT
14
46
253
0
0
27
@Towlie1981
Carlo Towl
8 months
All eyes on #AVCT 👀. Is this the start of the breakout?!
1
0
27
@Towlie1981
Carlo Towl
3 years
Calibre and Medusa have stated they have 'exceptional', 'worldwide', 'huge' demand for AffiDX/Meduflow in phone calls with PI's. #ABDX have stated they have 'substantial' pre orders via RNS. That 4-5m per month is looking conservative. Also AVA6000 RNS could land any day #AVCT
1
2
26
@Towlie1981
Carlo Towl
1 month
Post of the weekend. #AVCT #HolyGrail
@jivetur88775834
jive_turkey
1 month
@SeanDentBsc @AlanWoo13116320 @asininitybeyond None of these can be used by themselves as they are much too toxic, so they all need to be given with an ADC. However, note that ADCs are actually quite ineffective. The first ADC used dox as the warhead but it was effective enough (not enough made it into tumour cells).
1
0
20
0
0
27
@Towlie1981
Carlo Towl
2 years
@MylesMcNulty Exactly. Let the shorters make their profits. If you don't need the money then just sit tight. It's that simple. Everything is lined up for some life changing gains over the coming months/years. #AVCT
0
1
26
@Towlie1981
Carlo Towl
1 year
Bloody brilliant questions. 'Dox will be dox' when released in the tumour. And 'no reason why 6k wouldn't become standard of care for vast majority of $bn+ dox market' #AVCT
@paul_sped
Paul Spedding
1 year
Love the last ‘6’ questions! #AVCT
0
0
7
0
0
26
@Towlie1981
Carlo Towl
9 months
@PatsyeStevenson I'm sure the vast majority of good cops working hard for their communities would disagree that ACAB.
0
0
25
@Towlie1981
Carlo Towl
2 years
They're on 🔥 at the moment! #AVCT
@avacta
Avacta
2 years
AffyXell joint venture milestone and increased equity stake. #AVCT
8
24
159
0
0
25
@Towlie1981
Carlo Towl
2 months
@Blueberrymgmnt I've been looking at the comparator AS gave Ambrx. Very similar stage to #AVCT (but single indication drug) with good P1/2 results. Had fast track. Worth $500m prior to data. Raised $75m last yr. SP dropped for 2 wks after data drop then 2 months later bought for $2bn.
3
2
25
@Towlie1981
Carlo Towl
17 days
@coughlin582 @avacta The long rumoured/want of FAPI-PET imaging is finally being used in the trial. Hurrah!
0
0
26
@Towlie1981
Carlo Towl
2 years
One step closer. Great news. Buy and hold #AVCT
@avacta
Avacta
2 years
Avacta announces second dose escalation in the Phase I clinical study of AVA6000 Pro-doxorubicin. #AVCT
12
53
255
0
2
24
@Towlie1981
Carlo Towl
2 years
@Bill_Esterson 👏Finally MPs are giving this the attention it deserves! Keep digging and you will find it's a lot worse than you thought. @JNHanvey has all the details.
0
2
25
@Towlie1981
Carlo Towl
1 month
New interest from BP alongside existing interest. Anyone with half a brain could have worked that one out, but nice to hear it from the horse's mouth #AVCT
@BigBiteNow
BBN
1 month
All the major pharma companies stopped by to look at the (AVA6000) data. Some conversations were furthering ongoing ones. That'll do for me #AVCT .
0
3
55
2
1
25
@Towlie1981
Carlo Towl
2 years
#AVCT went to 100p on speculation AVA6000 was working. We now know it is working. Go figure 🤔
2
1
23
@Towlie1981
Carlo Towl
3 years
@Weston_Labour @DeborahMeaden Hang on. Wasn't the previous Socialist Labour alternative rejected by the country twice in elections? This country doesn't want socialism, it's that simple. Blair only won because he pegged back towards the centre. That's where they need to be.
3
0
21
@Towlie1981
Carlo Towl
3 years
@Ophidian18 You were bang on with your Mologic info earlier this year so let's hope your Medusa info is similarly accurate 🤞
1
0
23
@Towlie1981
Carlo Towl
1 year
So glad I was mentally prepared for this drop. Substantially de-risked awaiting the inevitable buyout. Could be this quarter, could be in years, but it will almost certainly be bought. If it isn't the rise will be choppy up to being a medium to large pharma. Happy to wait. #AVCT
1
1
24
@Towlie1981
Carlo Towl
1 year
You love to see it. Again. #AVCT
Tweet media one
@avacta
Avacta
1 year
First Patient Dosed in Fifth Cohort of AVA6000 Phase Ia Dose Escalation Study. #AVCT
1
48
227
0
1
24
@Towlie1981
Carlo Towl
6 months
#AVCT CEO states this in an RNS: "Targeting potent therapies to the tumour, while limiting the systemic toxicity that often characterises these therapies, is one of the holy grails of cancer drug development. The potential of the...
2
1
24